{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T06:48:45Z","timestamp":1700030925492},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,6,2]],"date-time":"2005-06-02T00:00:00Z","timestamp":1117670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00277-005-1060-2","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T15:00:11Z","timestamp":1117638011000},"page":"694-695","source":"Crossref","is-referenced-by-count":6,"title":["Successful treatment of a patient with myelodysplastic syndrome (RAEB) with Darbepoetin-alfa in combination with Pegfilgrastim"],"prefix":"10.1007","volume":"84","author":[{"given":"Andreas","family":"Jakob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich W.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,6,2]]},"reference":[{"key":"1060_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood-2003-07-2252","volume":"104","author":"N Casadevall","year":"2004","unstructured":"Casadevall N, Durieux P, Dubois S et al (2004) Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Blood 104:321\u2013327","journal-title":"Blood"},{"key":"1060_CR2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.2003.04153.x","volume":"120","author":"E Hellstrom-Lindberg","year":"2003","unstructured":"Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G et al (2003) A validated decision model for treating the anemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol 120:1037\u20131046","journal-title":"Br J Haematol"},{"key":"1060_CR3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00062752-200005000-00005","volume":"7","author":"Seipelt","year":"2000","unstructured":"Seipelt et al (2000) Cytokine therapy for myelodysplastic syndrome. Curr Opin Hematol 7:156\u2013160","journal-title":"Curr Opin Hematol"},{"key":"1060_CR4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00432-002-0372-z","volume":"128","author":"C Kasper","year":"2002","unstructured":"Kasper C, Zahner J, Sayer HG (2002) Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. J Cancer Res Clin Oncol 128:497\u2013502","journal-title":"J Cancer Res Clin Oncol"},{"key":"1060_CR5","first-page":"44","volume":"86","author":"P Musto","year":"2001","unstructured":"Musto P, Sanpaolo G, D\u2019Arena G et al (2001) Adding growth factors or IL-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone. Haematologica 86:44\u201351","journal-title":"Haematologica"},{"key":"1060_CR6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood-2002-06-1774","volume":"101","author":"R Tehranchi","year":"2003","unstructured":"Tehranchi R, Fadeel B, Forsblom AM et al (2003) Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood 101:1080\u20131086","journal-title":"Blood"},{"key":"1060_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.2004.05086.x","volume":"126","author":"GM Rigolin","year":"2004","unstructured":"Rigolin GM, Porta MD, Ciccone M et al (2004) In patients with myelodysplastic syndromes response to rhEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells. Br J Haematol 126:501\u2013507","journal-title":"Br J Haematol"},{"key":"1060_CR8","first-page":"3671","volume":"96","author":"BD Cheson","year":"2000","unstructured":"Cheson BD, Bennett JM, Kantarjian H et al (2000) Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 96:3671\u20133674","journal-title":"Blood"},{"key":"1060_CR9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2141.2004.05288.x","volume":"128","author":"P Musto","year":"2004","unstructured":"Musto P, Lanza F, Balleari E et al (2004) Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes. Br J Haematol 128:204\u2013209","journal-title":"Br J Haematol"},{"key":"1060_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00277-004-0961-9","volume":"84","author":"MAA Spiriti","year":"2005","unstructured":"Spiriti MAA, Latagliata R, Niscola P et al (2005) Impact of a new dosing regimen of epoetin alfa on quality of life an anemia in patients with low-risk myelodysplastic syndrome. Ann Hematol 84:167\u2013176","journal-title":"Ann Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-1060-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-005-1060-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-1060-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:44:51Z","timestamp":1559036691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-005-1060-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,2]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-1060-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,2]]}}}